Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy

Sexually Transmitted Diseases

Volumn 32, Issue 5, 2005, Pages 314-320

  Diamond, Catherine ^a,c   Taylor, Thomas H ^a   Aboumrad, Tabatha ^b   Bringman, Deborah ^a   Anton Culver, Hoda ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b S Diego Co Hlth/Hum Serv Agy   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANUS CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER INVASION; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; GEOGRAPHIC DISTRIBUTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; MALE; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; CALIFORNIA; CARCINOMA, SQUAMOUS CELL; HUMANS; INCIDENCE; MALE; MIDDLE AGED; REGISTRIES;

EID: 17744393024     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000162366.60245.02     Document Type: Article

References (25)

1. Walboomers JMM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-19.
2. Frisch M, Biggar RJ, Goedert JJ, et al. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92:1500-1510.
3. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992; 41:RR-17.
4. Melbye M, Cote TR, Kessler L, et al. High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet 1994; 343:636-639.
5. Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003; 183:453-459.
6. Grulich AE, Yueming L, McDonald A, et al. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 2002; 16:1155-1161.
7. Daling JR, Weiss NS, Hislop TG, et al. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 1987; 317:973-977.
8. Penn I. Cancers of the anogenital region in renal transplant recipients: Analysis of 65 cases. Cancer 1986; 58:611-616.
9. Percy C, Muir C, eds. International Classification of Diseases for Oncology. Geneva: World Health Organization, 1990.
10. Estève J, Benhamou E, Raymond L. Descriptive epidemiology. In: Statistical Methods in Cancer Research. Lyon: International Agency for Research on Cancer, 1994:52, 63-64.
11. O'Brien TR, Kedes D, Ganem D, et al. Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: Rates, risk factors, and relationship to Kaposi's sarcoma. J Infect Dis 1999; 180:1010-1017.
12. zur Hausen H. Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 1977; 78:1-30.
13. Holly EA, Whittemore AS, Aston DA, et al. Anal cancer incidence: Genital warts, anal fissure or fistula, hemorrhoids, and smoking. J Natl Cancer Inst 1989; 81:1726-1731.
14. Critchlow CW, Surawicz CM, Holmes KK, et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: Influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 1995; 9:1255-1262.
15. Palefsky JM, Holly EA, Ralston ML, et al. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12:495-503.
16. Palefsky JM, Holly EA, Ralston ML, et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immun Defic Syndr 2001; 28:422-428.
17. Fox P, Stebbing J, Portsmouth S, et al. Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapy. AIDS 2003; 17:279-280.
18. Piketty C, Darragh TM, Heard I, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004; 31:96-99.
19. International Collaboration on HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000; 92:1823-1830.
20. Dorrucci M, Suligoi B, Serraino D, et al. Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy. J Acquir Immun Defic Syndr 2001; 26:377-380.
21. Melbye M, Rabkin C, Frisch M, et al. Changing patterns of anal cancer incidence in the United States. Am J Epidemiol 1994; 139:772-780.
22. Cress RD, Holly EA. Incidence of anal cancer in California: Increased incidence among men in San Francisco, 1973-1999. Prev Med 2003; 36:555-560.
23. Ryan H, Wortley PM, Easton A, et al. Smoking among lesbians, gays, and bisexuals: A review of the literature. Am J Prev Med 2001; 21:142-149.
24. Place RJ, Gregorcyk SG, Huber PJ, et al. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma. Dis Colon Rectum 2001; 44:506-512.
25. Matthews WC. Screening for anal dysplasia associated with human papillomavirus. Top HIV Med 2003; 11:45-49.